Record €16.2 billion exports from Enterprise Ireland client companies in 2012

North American Market leads the way with 20% export growth in 2012

Enterprise Ireland client companies achieved record exports in 2012 breaking €16bn for the first time, up from €15.2bn in 2011. The outstanding geographical performance came from USA, where exports grew by 20%.

The main growth sectors to USA were software, lifesciences, including medical devices, business services and advanced engineering. Forty two percent of all software exported by Irish companies is sold in USA.

Executive Director for North America Gerry Murphy said: “This was an outstanding achievement by Irish owned companies in a year of sluggish economic growth in the US. We are proud of the companies we work with and their tremendous achievement in continuing to increase export sales which are crucial in sustaining and growing jobs in Ireland. As the world’s largest technically advanced economy, the United States is a key trading partner for Ireland and offers a relatively low-risk operating environment for Irish businesses”.

He thanked the members of the Irish Diaspora in USA who continue to provide a crucial role in mentoring and advising Irish companies and linking them with business opportunities

Enterprise Ireland is increasing its activities to support clients win new export business and build business networks and partnerships across America.

2013 will see a record number of trade missions and trade fairs in sectors as diverse as Financial Software, Telecommunications, Digital Media, Oil and Gas, Animation, Information Security and Healthcare, all aimed at linking Irish companies to American buyers.

On a recent visit to New York the Minister for Small Business John Perry TD, met with a number of Irish companies based in New York who are developing export business in the USA.
Pictured Left to Right: Noel Kilkenny, Consul General; Gerard Bermingham, Information Mosaic; Neil Cullen, Interactive Services; Gerry Murphy, Director Enterprise Ireland; Joanna Gardiner, Ovelle; John Perry TD, Minister for Small Business; Molly Dineen, UCD; Jim Milliard, Information Mosaic; Cillian Kieran, CKSK; and Mark Dorosz, Interactive Services

Sean Bay, Sales Director and Co-Founder demonstrating the SureWash technology to An Taoiseach, Enda Kenny T.D. at the Pacific Science Center

An Taoiseach (Head of the Government of Ireland), Enda Kenny T.D. visited the Pacific Science Center in Seattle, Washington on the 22^nd of March to meet with the Enterprise Ireland technology company, SureWash.

Dublin-based SureWash have developed an interactive hand-hygiene training system with three core benefits – the ability to save money, time and lives – which the company now intends to leverage in the US market.

Since the signing of the Patient Protection and Affordable Care Act (more commonly known as “Obamacare”), the emphasis on cost-containment and reduction in the US healthcare environment cannot be underestimated. SureWash’s technology has the ability to save money by reducing the labour needed to train and audit hand-hygiene compliance – the first core benefit of the technology. Secondly, the technology can also save the time associated with hand-hygiene training and compliance by providing e-learning to healthcare professionals on hospital wards at their convenience.

Significantly, SureWash’s technology promotes effective hand-hygiene techniques which can lead to a reduction in hospital acquired infections and ultimately save lives. The importance of hand-hygiene in the US hospital environment should be underestimated – it is estimated that approximately 100,000 Americans die annually from hospital acquired infections with an associated cost for treating these infections of approximately $30 billion each year. The World Health Organization (WHO) estimate that 50% of these hospital acquired infections could be prevented by better hand-hygiene – validating the need for SureWash’s technology in the US hospital environment.

The purpose of the Taoiseach’s visit to the Pacific Science Center was to acknowledge the inclusion of the SureWash technology in a new health and wellness exhibition. The “WellbodyAcademy” is the first new permanent exhibition in the Pacific Science Center in more that a decade and was established to demonstrate good living practices in hygiene, nutrition, exercise and sleep.

The inclusion of SureWash’s hand-hygiene training system in the new exhibition was supported by a group of clinical experts associated with the Pacific Science Center. Furthermore, each of the three SureWash hand-hygiene training systems on display were sponsored directly by the Seattle Children’s Hospital – further validating the opportunity for SureWash’s technology in the US healthcare environment.

Following a demonstration of the SureWash technology, the Taoiseach congratulated SureWash’s Sales Director and Co-Founder, Sean Bay on their inclusion in the new exhibition and acknowledged SureWash as an example of an Irish technology company that had developed an innovative solution for a global problem. The Taoiseach made reference to the significant impact that SureWash’s technology had made in the Mater Hospital in Dublin and wished the company success as they introduce the solution to the hospitals in the US.

From Dublin, SureWash has forged strong links with the Seattle area through the use of Microsoft licensed solutions and the Microsoft Kinect Camera in their interactive training system and the Pacific Science Center where their technology is on display is strongly supported by the Bill & Melinda Gates Foundation. Also in attendance at the event were a number of SureWash’s key contacts in the Seattle area including representatives from Group Health Cooperative, Seattle Children’s Hospital and the North West Kidney Centers.

Find out more about SureWash at www.surewash.com or follow on Twitter @surewash!

An Taoiseach, Enda Kenny T.D. speaking at SureWash event at the Pacific Science Center

Pictured from L to R: Scott Armstrong, Group Health Cooperative; An Taoiseach, Enda Kenny T.D.; Dr. Sanford Melzer, Seattle Children’s Hospital; Michal Anderson, Pacific Science Center; and Sean Bay, SureWash

All photographs courtesy of © Shelly Oberman Photography

At any recent life sciences gathering, there is a constant debate about the future of the venture capital model. Since 2000, the number of venture capital firms has halved and the amount of money available to VC firms to invest has also decreased significantly. For six Irish life sciences companies the 2013 J.P. Morgan Healthcare Conference provided an opportunity to grab the attention of potential investors, senior industry executives and key opinion leaders.

From a venture capital and business development perspective, the J.P. Morgan Healthcare Conference in San Francisco is arguably the most important event of the entire year for the health care sector.

In fact, the J.P. Morgan Healthcare Conference has had such a large impact on the life sciences community that a number of supplementary conferences aimed specifically at early stage technology companies now take place in conjunction with the main conference. While issues and trends in the US healthcare system, med tech and biopharma industries are discussed at the J.P. Morgan Healthcare Conference – life sciences entrepreneurs such as Jerry O’Brien of Cork-based point-of-care diagnostic Radisens pitch their offerings and solutions to potential investors and partners at conferences like OneMedForum.

Genesis VMI – an Irish software company with an inventory management solution for the operating room environment – recognize that coming to the J.P. Morgan Healthcare Conference is not just about attending seminars. Managing Director of Genesis VMI, Noel O’Hanlon commented that “it is really about the opportunity to meet with potential healthcare investors and potential technology partners from around the world – all in San Francisco for one week”.

This year, with six Irish life sciences companies ascending on San Francisco for this increasingly popular event, Enterprise Ireland organized a reception with some key opinion leaders, investors and deal-makers. Among the attendees, were Tom Loarie (Chairman of Mercator and also a member of Enterprise Ireland’s Medical Device Advisory Council – a group of experts in the US medical device industry that have an interest in helping Irish medical device companies succeed in the US), Nola Masterson (Managing Director of Science Futures – a life sciences investment firm), Randall Lashinski (CEO of Claret Medical – a catheter medical device company that has worked with a number of Irish companies), John MacMahon (COO of Maya Medical – a medical device company owned by Covidien and currently working with a number of Irish companies), Laurence McGrath (Executive Director US Healthcare Analyst at JP Morgan) and Bruce Jenett (Co-Chair of the Global Life Sciences Sector of, DLA Piper).

Other Irish life sciences companies in attendance included point-of-care diagnostic company, Biosensia; medical device company, Neuravi; drug discovery company, Sigmoid Pharma; and novel platform technology company, TriMod Therapeutics.

George Moore, a US-based specialist in the field of data/precision analytics, has been announced as the technology Start-up Ambassador for the US, as part of its strategy to promote Ireland and to encourage overseas entrepreneurs to locate their start-up businesses in Ireland. This follows on from earlier appointments of Start-Up Ambassadors for key markets in the UK, China and Middle East, and for the life sciences sector in the US.

Mr Moore is a pioneer in the development of real time analytics and information technology for business applications, with many years experience in the region.  He has particular expertise in the area of consumer scoring technologies for real time applications in the telecom, media, and retail industries.  He will now bring this vast experience to working closely with Enterprise-Ireland to highlight Ireland and what it has to offer for technology start-ups.

This announcement marks the fifth international start-up ambassador appointed by Enterprise Ireland over the past year.  It follows on the appointment of Dylan Collins for the UK market, Paul Kenny for the Middle East, Liam Casey for the Greater China Region, and Dr Art Rosenthal as Life Sciences Start-up Ambassador for the US.

The announcement follows on the launch late last year of a dedicated €10 million International Start-Up Fund to target investor ready overseas entrepreneurs to start their business inIreland.  Administered by Enterprise Ireland, the fund is open to company promoters anywhere in the world, but is targeted particularly at the Irish Diaspora, international expatriates, the ‘New Diaspora’ (people from overseas who have previously worked or studied in Ireland), as well as serial and mobile entrepreneurs.

Lorcan O’Sullivan, Manager of Enterprise Ireland’s Overseas Entrepreneurship Department, said:  ‘We are delighted to have a high profile figure such as George Moore as a US Ambassador for Enterprise Ireland’s international start-ups programme. George has not only experience of running large multinational operations, he has also extensive knowledge of start-ups as an investor. An increasing number of mobile international entrepreneurs are coming to Ireland as their location of choice to start a new business.  The volume of enquiries is double that of last year and this is certainly encouraging for us.  It is a tremendous boost to have a person of the calibre of George Moore, with his extensive experience and business networks and based locally in the US, who can support this programme and share his experience with other US entrepreneurs looking to start up in Ireland’.

George Moore added:

‘No one ever started a large company!  All companies including such Fortune 500 companies as HP, Intel, Microsoft and Google were start-ups and all began as an idea with smart people, experienced advisors, luck, and access to capital.  I look forward to working with Enterprise Ireland to drive entrepreneurial enterprises to Ireland’.

To find out more about the International Start-Up Fund and Ireland as a location for your business visit: www.startinireland.com

It’s one of the largest and fastest growing economies in the States – a centre for IT innovation, aerospace and defence manufacturing, beef barons and oil tycoons and home to the SXSW music and media showcase. And in March 2013, and it will be the destination for an Enterprise Ireland ministerial-led cross-sectoral trade mission.

In the latest edition of Enterprise Ireland‘s The Market magazine, Nick Marmion looks at why it’s hats off to the Lone Star State.

Texas is the second largest economy in the United States and the 15th largest in the world. What’s more, it’s the largest exporter of goods in the US: Texas currently grosses more than $100 billion a year in trade with other nations. It’s also home to 51 Fortune 500 companies, making it third in line after New York (with 57) and California (53). Irish companies with operations in Texas include Intuition, Kentz, Sercom, Firecomms, Icon and Trintech. But we believe the state presents further, and as yet barely exploited, opportunities for Irish companies to sell goods and services, develop partnerships and explore research linkages. In March 2013, we will co-ordinate a ministerial-led, cross-sectoral trade mission to Texas, taking in Dallas, Houston and Austin. This should be of particular interest to companies with solutions in the areas of:

• Wireless telecoms, chip and ICT manufacturing
• Medical device and IT for life sciences
• Oil and gas
• Smartfarm products for the dairy and cattle industries

DIVERSIFIED ECONOMY

One of the first industries to thrive in Texas after the civil war was cattle. Due to its long history as a centre of the livestock industry, Texas is associated with the image of the cowboy.

However, the state’s fortunes expanded in the early 20^th century, when the oil started to flow. With strong investments in universities, Texas has developed a diversified economy and high-tech industry. Today, it is a leader in many industries, including agriculture, petrochemicals, energy, computers and electronics, aerospace and biomedical sciences.

ICT HUB

Texas is one of the major hubs in the US for computer components and systems, as well as software. The Austin area is often referred to as ‘Silicon Hills’ because of the concentration of semiconductor design companies. Dell’s headquarters are located in the city’s suburb, Round Rock. Dallas is the birthplace of the integrated circuit, and by some definitions, the birthplace of the microprocessor. The North Dallas area has a high concentration of IT companies such as Texas Instruments and EDS. In addition, Harris County-based Compaq was once one of the world’s largest computer companies, and since Compaq’s merger with Hewlett-Packard, HP currently employs more employees in the Houston area than anywhere else in the world.

ENERGY CAPITAL

Texas is a global leader in the energy industry, and Houston is the energy capital of the world. The known petroleum deposits of Texas are about 8 billion barrels – or approximately one third of known US supply. As wells are depleted in the eastern portions of the state, drilling has moved westward. Several of the major oil companies have headquarters in Texas, including Conoco Phillips, Marathon Oil (Houston), Exxon-Mobil (Irving), Tesoro, and Valero (San Antonio). In addition, many of the world’s largest oilfield services firms, including Halliburton, Schlumberger and Dresser, have made Texas home, and major pipeline operators, such as El Paso and Dynegy, along with diversified energy firms such as TXU and Reliant Energy, are also there.

Since 2003, Texas state officials have created various initiatives like the Texas Enterprise Fund and the Texas Emerging Technology Fund to develop the economy of Texas. Texas has become a leader in alternative energy sources, producing more wind power than any other state, and it has also invested in small-scale solar power and experimental wave power generators.

DEFENCE

A large number of defence contractors are located in Dallas and Houston, creating strong employment for the state. Two divisions of Lockheed Martin have their headquarters in the Dallas-Fort Worth (DFW) area. Lockheed Martin Aeronautics in Fort Worthis where the F-16 Fighting Falcon, the largest Western fighter craft – and its successors the F-35 Lightning II and the F-22 Raptor – are manufactured. Lockheed Martin Missiles and Fire Control is headquartered in Grand Prairie.

MUSIC AND MEDIA

Running from March 10 to 13, 2013, the Irish trade mission will coincide with the South by Southwest (SXSW) annual week of conferences and festivals. SXSW has become an increasingly important destination for Irish companies interested in the convergence of music, film, internet and emerging technologies, and we expect 30 to 40 client companies from these sectors alone to travel to Houston between March 8 and 17, 2013. So it’s come to Houston – and Dallas, and Austin.

For further information, contact Nick Marmion, Enterprise Ireland’s US West Coast Manager, nick.marmion@enterpriseireland.com, +1 650 294 4081.

Enterprise Ireland and a wide range of Irish life sciences companies have been attending the Medical Innovation Summit at the Cleveland Clinic for several years now, and despite super storm Sandy, 2012 would be no different.

The 10th annual Medical Innovation Summit took place at the end of October in Cleveland, Ohio and although the subject matter changes annually, the caliber of discussion, attendees and networking opportunities remains strong.

Irish companies such as X-Bolt Orthopaedics are an example of an Irish company with an innovative solution in the orthopaedic space – but with key opinion leaders, surgeons and decision makers from all areas of the US health care system attending the summit, Irish software, health technology, tele health and service companies all travelled to Cleveland, Ohio.

Despite the political gain associated with making references to the state of Ohio in the recent Presidential race, it should not be seen as a surprise that both President Obama and the challenger paid homage to the Cleveland Clinic in the first debate. Renowned for its efforts in technological innovation, the Cleveland Clinic was once described as the “Toyota factory” of the US health care ecosystem by Newsweek. With an annual spend of $450 million on research and development -  over 20% of their entire expenditure – it is easy to see why the Cleveland Clinic could be considered as the innovation epicenter of the US health care system.

There was no doubt that the summit was an innovation epicenter for the duration of the summit this October.

The event began with a special break-out session for the delegation of Irish attendees in the Global Cardiovascular Innovation Center– a location where Irish companies Rigney Dolphin, Creganna-Tactx Medical and Proxy Biomedical have used to launch their US activities, increase exports to the US and ultimately create employment back in Ireland.

This year, the special breakout session for Irish attendees centered around a discussion on the purchasing process at large medical centers from Sean Lyden, MD, Chief Medical Officer for Supply Chain Management at the Cleveland Clinic.

Reduce cost, increase access and improve quality – the holy trinity for anybody involved in purchasing in the US health care industry. As far as the Cleveland Clinic or any other large medical center is concerned, if a vendor cannot demonstrate at least two of these features in their solution, then succeeding in the US is almost impossible.

While many Irish companies in the past have focused on a finding a large medical center as their first reference customer in the US, it is widely recognized that selling into such organizations can be a complex and time-consuming process. Ohio-based, management consultant Mark Saffran argued that targeting critical access hospitals, rural health clinics, nursing homes and assisted living centers are all alternative market-entry strategies that Irish companies should consider when looking at the US health care system.

With the special breakout session complete, over 1,000 CEOs, venture capitalists, innovators and health care leaders ascended on Cleveland for the start of the main summit.

With a dedicated exhibition space and platinum level sponsor exposure, Enterprise Ireland’s participation in the Medical Innovation Summit allows Irish companies to identify new business, partnership and collaboration opportunities.

Higlights of the summit included addresses from Kevin Lobo, CEO of Styker, Omar Ishrak, CEO of Medtronic and David Dvorak, CEO of Zimmer. Not to be outperformed by some of the leaders in orthopaedic technology, Watson - IBM’s supercomputer capable of answering questions posed in natural language - made a triumphant return to the Cleveland Clinic Medical Innovation Summit after devouring a number of leading cardiovascular surgeons in a game of Jeopardy! last year. This time Watson was back to announce that he will be attending medical school in an effort to learn everything your doctor knows and more. Primary care physicians everywhere beware…

Pictured above is the Bank of America Conference Center in the InterContinental Hotel on the Cleveland Clinic campus.

Looking at where VCs are putting their money is an easy way to identify sectors with perceived growth potential. The Affordable Care Act (known affectionately as “Obamacare”); a new additional 2.3% medical device tax; and continued uncertainty about the FDA approval process has led to big drop in VC funding dollars in the US life sciences industry in 2012. In fact, PwC have estimated that the medical device industry is down 30% in VC funding dollars and 22% in VC deals in Q2 2012 compared to the same period in 2011.

Remarkably, it does not seem that these challenges have impacted digital health, connected health, health technology or whatever term you might prefer to use. At the Health 2.0 San Francisco Fall event, the digital health accelerator RockHealth declared that VC funding dollars had increased by 70% and that VC deals had increased by 84% in Q3 2012 compared to the same period in 2011.

So it should not be surprising that when Governor of Massachusetts, Deval Patrick proclaimed that the third week in October would be known as “Innovation Week” in Boston that it was centered around two large health technology events.

The focus on the role of technology in healthcare began with a two-day event in the Massachusetts State House. The extensively named, “EU-US eHealth Marketplace & 2012 Transatlantic Health IT/eHealth Cooperation Assembly” was organised by the European Connected Health Alliance (ECH Alliance), the Northern Ireland Massachusetts Connection (NIMAC) and EU Commission. Essentially, the purpose of the event was to encourage the development of collaborations between the US and Europe in the area of connected health.

Among the attendees with a link to Enterprise Ireland were Irish companies SilverCloud Health and Cara Wellness whom exhibited and pitched their offerings at the assembly of 300 health tech executives, financiers, policy makers and health tech enthusiasts.

Headquartered in the National Digital Research Centre in Dublin, SilverCloud Health has a platform that allows healthcare providers and organisations to rapidly introduce health and wellness programs to their clients.

Through the collaboration of CASALA, ADA and Rigney Dolphin; CARAwellness has a technology that allows users gather information about their health from several technology sources so that they can keep an eye on their wellbeing and allow them share it with their carers. CARAwellness are able to do this through the use of medical technology, such as blood pressure cuffs, weight scales and sensors.

It was not just Irish health tech companies represented though – to promote eHealth Week 2013, Ciaran Cannon, T.D., Minister of State for Training and Skills concluded the two-day seminar with an invitation to all participants and their peers to come to the new convention centre in Dublin next May for the event – one of many conferences coinciding with Tourism Ireland’s “The Gathering 2013”.

Next up was the main event, the Connected Health Symposium 2012 presented by Partners HealthCare – the not-for-profit health care system that was founded by Brigham and Women’s Hospital and Massachusetts General Hospital.

The Connected Health Symposium prides itself on being the place where healthcare and technology collide – and they’ve been colliding annually for 9 years now in Boston. The discussions ranged from the policy driving “meaningful use” to discussions on how Americans are embracing solutions for health and wellness voluntarily – an estimated 60% of US adults are tracking their weight, diet or exercise routine voluntarily (albeit about half of these engaged Americans are what Susannah Fox of the Pew Internet & American Life Project described as “self trackers” – those who track their health using the popular “skinny jeans test”).

There’s a lot happening in health tech in the US at the moment and next year at eHealth Week 2013 in Dublin, Ireland Inc. will have its opportunity to showcase what the Irish health tech community can bring to the table.

Picture above is the main hall in the Massachusetts State House at the EU-US eHealth Marketplace & 2012 Transatlantic Health IT/eHealth Cooperation Assembly.

In October 2012, the Taoiseach, Enda Kenny TD, participated in a two day Enterprise Ireland programme to visit a number of Irish life sciences companies in Philadelphia and Cleveland.

The programme began with the official opening of Zenith Technologies’ new US headquarters in Philadelphia. With its global headquarters in Ireland, Zenith Technologies provides automation and manufacturing execution systems (MES) engineering services to the life sciences industry.

Speaking at the event, the Taoiseach acknowledged that Zenith Technologies and other leading high-technology companies supported by Enterprise Ireland would continue to drive export growth, underpin Ireland’s economic prosperity and support valuable Irish jobs in the future.

Also in attendance at the official opening of Zenith Technologies’ US headquarters were Allyson Schwartz, the U.S. Representative for Pennsylvania’s 13th congressional district; and Kate Harper and Brendan Boyle – both members of the Pennsylvania House of Representatives.

The event in Philadelphia was followed by a visit to the Cleveland Clinic where it was announced that the Irish-based company, i360medical has formed a strategic partnership with the Cleveland Clinic and its Innovation Alliance. Through the partnership, i360medical will represent the European wing of Cleveland Clinic’s Innovation Alliance programme which includes North Shore LIJ, MedStar Health, Promedica and Notre Dame.

Derek Young, founder and CEO of i360medical noted that the collaboration would facilitate the commercialisation of technology and innovative ideas in the healthcare industry using Ireland as a launch pad for emerging companies.

Enterprise Ireland has a long established relationship with the Cleveland Clinic, and the partnership between i360medical and Cleveland Clinic is the result of introductions brokered by Enterprise Ireland.

Speaking at an event in Cleveland Clinic, the Taoiseach said: “I strongly welcome this latest successful outcome of the relationship that exists between Ireland and the Cleveland Clinic. Healthcare and life sciences is a sector that holds particular potential for growth and job creation and is a key sector in the Government’s Action Plan for Jobs. This latest alliance is further endorsement of the international calibre of Ireland’s indigenous healthcare sector. The Government, through Enterprise Ireland, is keen to support and promote more strategic international collaborations such as this one to enhance innovation and generate break-through research. I trust that this will be a mutually beneficial alliance for both i360 Medical and Cleveland Clinic that will yield significant benefits for both organisations.”

The Taoiseach also met with a number of other Irish life sciences companies supported by Enterprise Ireland that have established a relationship with the Cleveland Clinic.

Pictured above from left to right at Cleveland Clinic: Dominic Considine; Richard Stack, M.D. Managing Director of Synergy Life Sciences Parnters; An Taoiseach, Enda Kenny TD; Derek Young, Founder and CEO of i360medical; Christopher Coburn, Executive Director of Cleveland Clinic Innovations; and Frank Ryan, Chief Executive Officer of Enterprise Ireland.

QUMAS – Complimentary Life Sciences Seminar

Implementing Compliance & Quality Management for Partner Collaboration Across Life Sciences

The Westin Princeton, Forrestal Village, New Jersey September 20, 2012

Join QUMAS for a complimentary seminar on “Implementing Compliance & Quality Management for Partner Collaboration across Life Sciences”, at The Westin Princeton at Forrestal Village, New Jersey, on September 20, 2012.

The seminar will focus on;

• The Growing Business Demands for Collaboration across the Life Sciences Industry
• Potential Regulatory, Operational and Reputational Impacts of Uncontrolled Collaboration
• How to Achieve Collaboration Maturity across the Enterprise, including Regulatory Affairs, Quality Assurance, Manufacturing and Supply Chain
• Technology and Validation Solutions for Addressing the Compliance Challenges Raised by Collaboration

The agenda will feature senior executives from the following organizations:

Alvogen

Microsoft

QUMAS

Glemser Technologies

LNS Research

Agenda:

8:00 – 8:30 – Registration & Continental Breakfast

8:30 – 9:15  – Managing Compliance as Collaboration & Outsourcing Increase across the Life Science Industry, Kevin O’Leary, CEO QUMAS

9:15 – 10:00 - Global Trends in Life Sciences: Addressing Collaboration and Quality Challenges, Matt Littlefield, President and Principal Analyst, LNS Research

10:00 – 10:30 – Coffee Break

10:30 – 11:15 - CIO Insights: Implementing Compliance and Quality Management Across the Enterprise, Joe Rutz, CIO, Alvogen

11:15 – 11:45 - Implementing Compliance & Quality Management across the Enterprise, Murtuza Vasowalla, Director, Global Solutions Consulting, QUMAS

11:45 – 12:30 - Best Practice Recommendations for Implementing Quality Solutions and Validation Implications for On Premise and Cloud Based Systems, Ray Glemser, President, Glemser Technologies

12:30 – 1:30 - Lunch

1:30 – 2:00 - Microsoft for Life Sciences: Enabling Collaboration, Les Jordan, Chief Technology Strategist, Microsoft Life Sciences

2:00 – 2:30 – Compliance Made Easy with QUMAS & Microsoft SharePoint 2010, Murtuza Vasowalla, Director, Global Solutions Consulting, QUMAS

2:30 – 2:45 - Executive Summary, Kevin O’Leary CEO

2:45 – Expert Panel – In-depth Q&A Session

Demos Available On Request

Please email info@qumas.com if you would like to schedule a detailed demonstration tailored to meet your specific requirements or focused on one of the following topics:

• Moving from a Legacy EDMS, including migration and implementation
• SOP Management & Collaboration
• CAPA, Deviation, Change Control
• QUMAS ComplianceSP as your QMS

Evening Dinner Invitation

QUMAS will be hosting a dinner in Princetonon on the evening of September 20, 2012 and would be delighted if seminar attendees were available to join us. Please indicate on the registration form if you are available to attend.

Please click here to register

Please click here to download the seminar invitation

For more information, please see:

www.qumas.com/nj

QUMAS LinkedIn

http://www.twitter.com/QUMAS

https://www.facebook.com/QUMAS

About QUMAS

QUMAS is the leader in Compliance and Quality Management Solutions for the Life Sciences industry, with more than 260 global customer deployments and domain expertise in regulatory compliance since 1994.

Last month, 100 representatives from over 40 Enterprise Ireland client companies gathered in the J.E. Cairnes School of Business & Economics, NUI Galway for a one-day seminar on winning business in the US medical device market. In attendance were a number of US-based senior executives from medical device giants such as Boston Scientific, Medtronic and Stryker.

The Enterprise Ireland office in Boston invited ten guest speakers from companies such as Boston Scientific, Medtronic, Terumo, Stryker, Arsenal Medical, Sapheon and MedCelerate to discuss the procurement process, regulatory approval, reimbursement and other key issues that must be understood in order to successfully export into the US medical device market.

The Enterprise Ireland event June also involved over 80 individual buyer meetings between client companies and the US-based senior executives, while John Power, CEO of Aerogen and Paddy Mulholland, Managing Director of VistaMed shared their experiences about successfully winning business in the US medical device market as an Irish company.

Speaking at the event, Gerry Murphy, Executive Director of Enterprise Ireland said “the US Med Device sector is undoubtedly the most important med device sector worldwide, valued at $127 Billion per annum and expected to reach over $151 Billion by 2015. This is a really practical way for Irish medical device companies to learn from US experts and proven Irish companies about how best to be successful in the world’s main market. Apart from the strategy and technical mentoring on offer, this event provides an opportunity for these Irish firms to meet executives and buyers in individual meetings. We expect business partnerships to begin at this event that will ultimately lead to increased exports.”

The medical technology sector continues to be a key success story for Ireland and is a very important contributor to the economy. The industry now employs over 25,000 people in over 250 companies, with exports of over €7.2 billion per annum which continues to grow year-on-year. In addition to the rich landscape of world leading multinational companies, Ireland has fostered the growth of a highly dynamic, vibrant and innovative indigenous company base. Indeed, with fifty percent of the Irish medical technology company base now composed by indigenous firms, the sector has never been in a stronger position to achieve success in the United States– the largest medical technology market in the world. The Enterprise Ireland office in Boston works with a wide-range of Irish medical technology companies looking to export to the US market.

Pictured above:

Back row from left to right: Eddie Goodwin, Manager Boston Office and VP Medical Technologies & Pharma at Enterprise Ireland; Dr. James Barry, Executive VP and COO at Arsenal Medical; Dr. Arthur Rosenthal, CEO at gEyeCue Medical Systems and recently appointed Enterprise Ireland Start-Up Ambassador and Dr. James Cunningham, Director of the Institute for Business, Social Sciences and Public Policy at NUI Galway.

Middle row from left to right: Marie O’Malley, Senior Director of Supply Management at Medtronic CardioVascular; Ken McDonnell, Global Business Development Director at Terumo Medical; Greg Davis, Founder & CEO at MedCelerate Consulting Group; Thomas Byrne at Director of Health Economics and Reimbursement, Boston Scientific Corporation and Gerry Murphy, Executive Director at Enterprise Ireland.

Front row from left to right: David Cassak, Managing Director Medical Devices at Windhover Information – Elsevier Business Intelligence; Ryder L. Russell, Director Research & Development/Director Divisional Quality Assurance at Stryker Corporation; Dr. James J. Browne, President at NUI Galway; Paddy Mulholland; Managing Director at VistaMed and Dr. Emer Mulligan, Head of School at J.E. Cairnes School of Business & Economics, NUI Galway.